跳至主要内容
临床试验/NCT03067168
NCT03067168Unknown不适用

A Multicenter, Double Blinded, Randomized Controlled Trial of Levator Muscle Blocks Following Posterior Colporrhaphy Surgery to Reduce Post-operative Pain.

The Christ Hospital3 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2017年5月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
128
试验地点
3
主要终点
Number of patients with improvement in pain, scored on a 10 point numerical pain scale.

研究概览

简要总结

To determine if levator muscle block with bupivacaine improves postoperative pain control relative to placebo controls among women undergoing prolapse surgery involving a posterior colporrhaphy. Improvement is defined as no less than a 25% lower total pain score on a ten point numerical pain scale.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Subjects will not know if they received an injection of bupivacaine or placebo, i.e., normal saline after completion of surgery. The surgeon, as well as any investigator or study personnel, will be blinded to injection type.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Any woman over the age of 18 years with a capacity to give informed consent who are undergoing vaginal prolapse surgery including a posterior colporrhaphy may be included in the study.

排除标准

  • Any woman who is a non-English speaker, does not have ability to provide consent, has a cardiac arrhythmia, liver disease, myasthenia gravis, bleeding diathesis or adverse reaction / allergy to anesthetic will be excluded. Women that are also having vaginal mesh excisions at the time of prolapse repair or those that will undergo subsequent surgery in the follow up period will be excluded.

研究组 & 干预措施

Bupivacaine Arm

Active Comparator

The subjects of this arm will receive an injection of 5mL of 0.5% bupivacaine, 1-2 cm deep to the surface of the vaginal epithelium into the levator ani muscle, puborectalis. A second injection of 5mL of 0.5% bupivacaine, 1-2 cm deep to the surface of the vaginal epithelium will be repeated on the same side, approximately 2-3 cm cephalad of the first injection at the iliococcygeus muscle. These 2 injections will then be repeated on the contralateral side.

干预措施: Bupivacaine (Drug)

Placebo Arm

Placebo Comparator

The subjects of this arm will receive an injection of 5mL of 0.9% normal saline, 1-2 cm deep to the surface of the vaginal epithelium into the levator ani muscle, puborectalis. A second injection of 0.9% normal saline, 1-2 cm deep to the surface of the vaginal epithelium will be repeated on the same side, approximately 2-3 cm cephalic from first injection at the iliococcygeus muscle. These 2 injections will then be repeated on the contralateral side.

干预措施: normal saline 0.9% (Drug)

结局指标

主要结局

Number of patients with improvement in pain, scored on a 10 point numerical pain scale.

时间窗: 1 year

Improvement is defined as a 25% or lower total pain score on a ten point numerical pain scale compared to placebo.

次要结局

  • Postoperative care satisfaction scores, graded with a post-operative survey.(1 year)
  • Measure of morphine equivalents used in patients postoperatively.(1 year)
  • Length of hospital stay measured in hours.(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carson T. Kaeser, MD

Fellow in Female Pelvic Medicine and Reconstructive Surgery

The Christ Hospital

研究点 (3)

Loading locations...

相似试验